PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Aqueous extracts of juice showed significant hypoglycemic, antidyslipidemic, antihyperglycemic, and antiobesity activities [PMID:36816233]
Aqueous extract from sisal waste (1.7 g/kg daily for 8 days) caused a significant reduction in fecal egg counts and worm counts [PMID:21156340]
Extracts demonstrated dose-dependent inhibition of egg hatch, larval development, and adult motility [PMID:22469785, PMID:23146415]
Agro-industrial residue extract reduced intracellular ROS and increased survival rates [PMID:33053674]
Certain steroidal saponins exhibited cytotoxic effects on MCF-7, NCI-H460, and SF-268 cells [PMID:21243587]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 37565318 (2023) — Use of sisal industrial waste (Agave sisalana Perrine) in sustainable and multifunctional cosmetic products. · International journal of cosmetic science
- 2.PMID: 34124368 (2021) — The complete chloroplast genome of Agave sisalana. · Mitochondrial DNA. Part B, Resources
- 3.PMID: 37050149 (2023) — Toxicity and Anti-Inflammatory Effects of Agave sisalana Extract Derived from Agroindustrial Residue. · Plants (Basel, Switzerland)
- 4.PMID: 30843373 (2019) — Multiple response optimization of alkaline pretreatment of sisal fiber (Agave sisalana) assisted by ultrasound. · Biotechnology progress
- 5.PMID: 36816233 (2023) — The significant antidyslipidemic, hypoglycemic, antihyperglycemic, and antiobesity activities of the aqueous extracts of Agave Sisalana juice are partly mediated via modulation of calcium signaling pathways.